Anticancer therapy and lung injury: molecular mechanisms

Li Li, Henry Mok, Pavan Jhaveri, Mark D. Bonnen, Andrew G. Sikora, N. Tony Eissa, Ritsuko U. Komaki, Yohannes T. Ghebre

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Introduction: Chemotherapy and radiation therapy are two mainstream strategies applied in the treatment of cancer that is not operable. Patients with hematological or solid tumor malignancies substantially benefit from chemotherapeutic drugs and/or ionizing radiation delivered to the site of malignancy. However, considerable adverse effects, including lung inflammation and fibrosis, are associated with the use of these treatment modalities. Areas covered: As we move toward the era of precision health, we are compelled to understand the molecular basis of chemoradiation-induced pathological lung remodeling and to develop effective treatment strategies that mitigate the development of chronic lung disease (i.e. fibrosis) in cancer patients. The review discusses chemotherapeutic agents that are reported to induce or associate with acute and/or chronic lung injury. Expert commentary: There is a need to molecularly understand how chemotherapeutic drugs induce or associate with respiratory toxicities and whether such characteristics are inherently related to their antitumor effect or are collateral. Once such mechanisms have been identified and/or fully characterized, they may be able to guide disease-management decisions including effective intervention strategies for the adverse effects. In the meantime, radiation oncologists should be judicious on the dose of radiation delivered to the lungs, the volume of lung irradiated, and concurrent use of chemotherapeutic drugs.

Original languageEnglish (US)
Pages (from-to)1041-1057
Number of pages17
JournalExpert Review of Anticancer Therapy
Volume18
Issue number10
DOIs
StatePublished - Oct 3 2018
Externally publishedYes

Keywords

  • Chemotherapy
  • lung fibrosis
  • lung inflammation
  • pulmonary toxicity
  • radiation therapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Anticancer therapy and lung injury: molecular mechanisms'. Together they form a unique fingerprint.

Cite this